Semaglutide pen

Semaglutide has a blood half-life of about 7 days, making it suitable for weekly injections.

Weeks 1–4 — 0.25 mg

Weeks 5–8 — 0.5 mg

Weeks 9–12 — 1 mg

From week 13 — 1–2 mg if needed

Injection site: Inject into your abdomen, thigh or upper arm

Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

It is used as an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.

It reduces food intake by lowering appetite and slowing down digestion in the stomach, helping to reduce body fat.

• Protein intake: 1.6–2.2 g per kg of body weight

• Regular strength training

• Electrolyte monitoring

• Monitor total calorie intake

• Fiber: 25–40 g per day

• Adequate water intake

• Avoid large high-fat meals, as they may increase nausea

• Electrolytes

• Magnesium

• Omega-3

• Vitamin D

Semaglutide reduces high blood sugar by increasing the amount of insulin released, decreasing the amount of glucagon released, and delaying gastric emptying. Semaglutide also controls appetite and helps reduce the amount of food a person wants to eat. In addition, Semaglutide reduces preference for high-fat meals.

In clinical studies, Semaglutide had a positive effect on plasma lipids, reduced systolic blood pressure and reduced inflammation. In animal studies, Semaglutide slowed the development of atherosclerosis by preventing the progression of aortic plaque development and reducing plaque inflammation.

Tell your doctor if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, hoarseness, or shortness of breath.

You should not use Semaglutide if you have multiple endocrine neoplasia type 2 (tumors in the glands) or a personal or family history of medullary thyroid cancer.

Ask your doctor about taking Semaglutide if you have ever had the following diseases or conditions:diabetic ketoacidosispancreatitis;kidney diseaseeye problems caused by diabetes (retinopathy).